BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • Dinney

    Colin P.N. Dinney, M.D.
    Chairman, Department of Urology
    M.D. Anderson Cancer Center
    Colin P. N. Dinney is the Chairman of the Department of Urology and a Professor in the Division of Surgery at The University of Texas M. D. Anderson Cancer Center.  Dr. Dinney received his medical degree from the University of Manitoba in Canada and did a two-year fellowship in urologic oncology at M. D. Anderson Cancer Center.  He is the PI of the M. D. Anderson Genitourinary SPORE in Bladder Cancer Research, which was awarded in September of 2001. In addition to administrating this program, he is actively involved in SPORE-related translational research. His bench and clinical research activities have focused on understanding the biology of metastatic bladder cancer and on the development of novel therapeutic strategies for both early and advanced disease. The major focus of his laboratory investigations has been the study of the role of angiogenesis and invasion of bladder cancer metastasis.  His bibliography includes more than 100 papers and book chapters covering a wide variety of topics in urologic oncology, with an emphasis on bladder cancer.
    Click here for more information.